[Treatment of infectious renal lithiasis with acetohydroxamic acid].
D000293:Adolescent; D000328:Adult; D001031:Apatites / Q000378:metabolism; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007669:Kidney Calculi / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008274:Magnesium / Q000378:metabolism; D017616:Magnesium Compounds; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000378:metabolism; D000069877:Struvite; D014510:Urease / Q000037:antagonists & inhibitors; D014552:Urinary Tract Infections / Q000150:complications*
D001031:Apatites; D006877:Hydroxamic Acids; D017616:Magnesium Compounds; D010710:Phosphates; C006358:acetohydroxamic acid; C030782:carboapatite; D000069877:Struvite; D014510:Urease; D008274:Magnesium
Tratamiento de la litiasis renal infecciosa con ácido acetohidroxámico.